Business
Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Confirmatory Clinical Trial for the Visualization of Bladder Cancer Surgery Using Aminolevulinic Acid Hydrochloride Granules
Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Confirmatory Clinical Trial for the Visualization of Bladder Cancer Surgery Using Aminolevulinic Acid Hydrochloride Granules
About this update from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A
Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Confirmatory Clinical Trial for the Visualization of Bladder Cancer Surgery Using Aminolevulinic Acid Hydrochloride GranulesThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment